IMBCR – Institute for Myeloma & Bone Cancer Research At IMBCR, we have boldly set out to reimagine how we approach treatment, management, and drug development strategies for multiple myeloma and other devastating malignancies. We focus on the individual needs of patients, not just treatment, but holistic care. Working alongside industry leaders and other centers of excellence from around the world, we explore available & novel drugs to determine the optimal, unconventional combinations to maximize their benefit. Our mission is to advance the treatment of myeloma by connecting possibilities through scientific innovation leading to personalized and continuous optimized patient care.